DASSEUX JEAN LOUIS has a total of 24 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Israel, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are NORTHSTAR BIOLOG PTY LTD, KOCHER THEODOR INST and CENT SYDNEY AREA HEALTH SERV.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | Norway | 3 | |
#6 | United States | 3 | |
#7 | China | 1 | |
#8 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dasseux Jean-Louis | 18 |
#2 | Sekul Renate | 16 |
#3 | Cornut Isabelle | 16 |
#4 | Metz Gunther | 13 |
#5 | Buttner Klaus | 13 |
#6 | Dufourcq Jean | 7 |
#7 | Metz Guenther | 3 |
#8 | Buettner Klaus | 3 |
#9 | Guenther Dasseux Jean-Louis Se | 1 |
Publication | Filing date | Title |
---|---|---|
IL135322D0 | Peptide/lipid complex formation by colyophilization | |
US6037323A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | |
US6046166A | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |